Giulio Molon, M.D.; Cosimo Perrone, M.D.; Massimiliano Maines, M.D.; Alessandro Costa, M.D.; Jennifer Comisso, M.D.; Alida Boi, M.D.; Eugenio Moro, M.D.; Giuseppe ...
In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...
Background: Multiple clinical trials have shown that a properly functioning implantable cardioverter-defibrillator (ICD) is capable of interrupting sudden death caused by ventricular tachyarrhythmias.
For older patients without an indication for pacing, the subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) provides results comparable to those seen with traditional ...
Medical Device Network on MSN
AtaCor raises $75m for trial of EV-ICD system
AtaCor Medical has raised $75m financing to support a study of its extravascular implantable cardioverter-defibrillator ...
Please provide your email address to receive an email when new articles are posted on . The FDA announced Medtronic has issued a recall of its implantable cardioverter defibrillators and cardiac ...
Patients who stayed active following ICD implantation had better survival rates that those who did not, a study concludes. They add that Information collected by ICD devices may one day help ...
Elderly patients diagnosed with congestive heart failure who receive implantable cardioverter-defibrillators for primary prevention of sudden cardiac death live longer than those that do not. Further, ...
The indications for ICD implantation continue to expand; however, these devices are associated with complications related to the implantation procedure itself and morbidity caused by the normal and ...
An analysis of more 800 MRI examinations shows the scans do not induce clinically significant functional changes in non-MRI-conditional implantable cardioverter defibrillators, data from a ...
ATLANTA, Oct. 6, 2020 /PRNewswire/ -- MedShape, Inc., the industry leader in orthopedic devices using advanced functional materials, today announced the U.S. Centers for Medicare & Medicaid Services ...
CHICAGO (Reuters) - Boston Scientific Corp's new leadless implantable heart defibrillator, hailed by some as a breakthrough, should be used on a limited basis until more data are collected, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback